From NASH to HCC: current concepts and future challenges QM Anstee, HL Reeves, E Kotsiliti, O Govaere, M Heikenwalder Nature reviews Gastroenterology & hepatology 16 (7), 411-428, 2019 | 1142 | 2019 |
NASH limits anti-tumour surveillance in immunotherapy-treated HCC D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ... Nature 592 (7854), 450-456, 2021 | 817 | 2021 |
Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease L Boulter, O Govaere, TG Bird, S Radulescu, P Ramachandran, ... Nature medicine 18 (4), 572-579, 2012 | 796 | 2012 |
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis O Krenkel, T Puengel, O Govaere, AT Abdallah, JC Mossanen, ... Hepatology 67 (4), 1270-1283, 2018 | 476 | 2018 |
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes M Komuta, O Govaere, V Vandecaveye, J Akiba, W Van Steenbergen, ... Hepatology 55 (6), 1876-1888, 2012 | 377 | 2012 |
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ... Journal of hepatology 73 (3), 505-515, 2020 | 358 | 2020 |
Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury JC Mossanen, O Krenkel, C Ergen, O Govaere, A Liepelt, T Puengel, ... Hepatology 64 (5), 1667-1682, 2016 | 317 | 2016 |
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas O Govaere, M Komuta, J Berkers, B Spee, C Janssen, F De Luca, ... Gut 63 (4), 674-685, 2014 | 275 | 2014 |
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis O Govaere, S Cockell, D Tiniakos, R Queen, R Younes, M Vacca, ... Science translational medicine 12 (572), eaba4448, 2020 | 241 | 2020 |
TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence TG Bird, M Müller, L Boulter, DF Vincent, RA Ridgway, ... Science translational medicine 10 (454), eaan1230, 2018 | 211 | 2018 |
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 209 | 2021 |
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis L Verbeke, I Mannaerts, R Schierwagen, O Govaere, S Klein, ... Scientific reports 6 (1), 1-12, 2016 | 209 | 2016 |
Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis L Hammerich, JM Bangen, O Govaere, HW Zimmermann, N Gassler, ... Hepatology 59 (2), 630-642, 2014 | 194 | 2014 |
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching L De Smedt, S Palmans, D Andel, O Govaere, B Boeckx, D Smeets, ... British journal of cancer 116 (1), 58-65, 2017 | 159 | 2017 |
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? R Younes, O Govaere, S Petta, L Miele, D Tiniakos, A Burt, E David, ... Gut 71 (2), 382-390, 2022 | 149 | 2022 |
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma R Janky, MM Binda, J Allemeersch, A Van den Broeck, O Govaere, ... BMC cancer 16, 1-15, 2016 | 149 | 2016 |
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis L De Smedt, J Lemahieu, S Palmans, O Govaere, T Tousseyn, ... British journal of cancer 113 (3), 500-509, 2015 | 141 | 2015 |
Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche O Govaere, J Wouters, M Petz, YP Vandewynckel, K Van den Eynde, ... Journal of hepatology 64 (3), 609-617, 2016 | 132 | 2016 |
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease R Younes, GP Caviglia, O Govaere, C Rosso, A Armandi, T Sanavia, ... Journal of hepatology 75 (4), 786-794, 2021 | 130 | 2021 |
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease M Boyle, D Tiniakos, JM Schattenberg, V Ratziu, E Bugianessi, S Petta, ... Jhep Reports 1 (3), 188-198, 2019 | 105 | 2019 |